YieldMax MRNA Option Income Strategy ETF (MRNY)
The MRNY ETF aims to generate monthly income by selling call options on Moderna Inc. ("MRNA") while also seeking exposure to MRNA's stock price gains with capped participation. The fund's primary goal is current income with a secondary objective of capturing gains from MRNA's stock price within limits.
ETF Info
88634T469
Oct 23, 2023
1x
No Index (Active)
Distributing
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in YieldMax MRNA Option Income Strategy ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
YieldMax MRNA Option Income Strategy ETF had a return of -61.95% year-to-date (YTD) and -53.06% in the last 12 months.
MRNY
-61.95%
-23.15%
-68.80%
-53.06%
N/A
N/A
^GSPC (Benchmark)
24.72%
1.67%
12.93%
30.55%
13.88%
11.16%
Monthly Returns
The table below presents the monthly returns of MRNY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -0.39% | -4.45% | 13.90% | 3.28% | -4.89% | -14.82% | 4.00% | -30.05% | -10.50% | -14.27% | -61.95% | ||
| 2023 | -3.72% | -1.39% | 25.99% | 19.61% |
Expense Ratio
MRNY has a high expense ratio of 0.99%, indicating higher-than-average management fees.
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of MRNY is 0, indicating that it is in the bottom 0% of ETFs on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for YieldMax MRNA Option Income Strategy ETF (MRNY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
YieldMax MRNA Option Income Strategy ETF provided a 186.73% dividend yield over the last twelve months, with an annual payout of $9.58 per share.
| Period | TTM | 2023 |
|---|---|---|
| Dividend | $9.58 | $0.41 |
Dividend yield | 186.73% | 1.75% |
Monthly Dividends
The table displays the monthly dividend distributions for YieldMax MRNA Option Income Strategy ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $2.65 | $0.59 | $1.13 | $0.78 | $0.95 | $0.84 | $0.49 | $0.47 | $0.48 | $0.38 | $0.40 | $9.17 | |
| 2023 | $0.41 | $0.41 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the YieldMax MRNA Option Income Strategy ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the YieldMax MRNA Option Income Strategy ETF was 70.50%, occurring on Nov 15, 2024. The portfolio has not yet recovered.
The current YieldMax MRNA Option Income Strategy ETF drawdown is 69.37%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -70.5% | May 28, 2024 | 121 | Nov 15, 2024 | — | — | — |
| -20.83% | Jan 9, 2024 | 25 | Feb 13, 2024 | 28 | Mar 25, 2024 | 53 |
| -11.09% | Oct 25, 2023 | 12 | Nov 9, 2023 | 21 | Dec 11, 2023 | 33 |
| -6.19% | Mar 28, 2024 | 4 | Apr 3, 2024 | 4 | Apr 9, 2024 | 8 |
| -5.64% | May 3, 2024 | 6 | May 10, 2024 | 3 | May 15, 2024 | 9 |
Volatility
Volatility Chart
The current YieldMax MRNA Option Income Strategy ETF volatility is 15.45%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.